Chemotherapy of second stage human African trypanosomiasis: comparison between the parenteral diamidine DB829 and its oral prodrug DB868 in vervet monkeys.
Human African trypanosomiasis (HAT, sleeping sickness) ranks among the most neglected tropical diseases based on limited availability of drugs that are safe and efficacious, particularly against the second stage (central nervous system [CNS]) of infection. In response to this largely unmet need for...
Saved in:
Main Authors: | John K Thuita (Author), Kristina K Wolf (Author), Grace A Murilla (Author), Arlene S Bridges (Author), David W Boykin (Author), James N Mutuku (Author), Qiang Liu (Author), Susan K Jones (Author), Charles O Gem (Author), Shelley Ching (Author), Richard R Tidwell (Author), Michael Z Wang (Author), Mary F Paine (Author), Reto Brun (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2015-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety, pharmacokinetic, and efficacy studies of oral DB868 in a first stage vervet monkey model of human African trypanosomiasis.
by: John K Thuita, et al.
Published: (2013) -
Pharmacology of DB844, an orally active aza analogue of pafuramidine, in a monkey model of second stage human African trypanosomiasis.
by: John K Thuita, et al.
Published: (2012) -
Trypanosoma brucei rhodesiense transmitted by a single tsetse fly bite in vervet monkeys as a model of human African trypanosomiasis.
by: John K Thuita, et al.
Published: (2008) -
Development of a safer laboratory vervet monkey model for the study of human African trypanosomiasis
by: Maxwell Waema, et al.
Published: (2014) -
Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice
by: Panshuang Qiao, et al.
Published: (2022)